Uruguay hosted a technical delegation from Brazil’s National Health Surveillance Agency (ANVISA) on a visit aimed at strengthening bilateral cooperation in medical cannabis. The agenda included discussions on regulatory issues, tours of companies, and meetings with various stakeholders in the sector. Brazil has established itself as the dominant player in the export of medicines and active pharmaceutical ingredients, with approximately 2.4 tons and over $450,000 exported to Uruguay in 2025.